Human apoE isoforms differentially regulate brain amyloid-Î² peptide clearance.
Sci Transl Med., Jun;3(89):89ra57 (2011)
Effects of age and amyloid deposition on AÎ² dynamics in the human central nervous system.
Arch. Neurol., Jan;69(1):51-8 (2012)
Measurement of apolipoprotein E and amyloid Î² clearance rates in the mouse brain using bolus stable isotope labeling.
Mol Neurodegener., 7:14 (2012)
Clinical and biomarker changes in dominantly inherited Alzheimer's disease.
N. Engl. J. Med., Aug;367(9):795-804 (2012)
Disruption of the Sleep-Wake Cycle and Diurnal Fluctuation of Î²-Amyloid in Mice with Alzheimer's Disease Pathology.
Sci Transl Med., Sep;4(150):150ra122 (2012)
Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ.
J. Biol. Chem., Aug;281(34):24566-74 (2006)
Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo.
Nat. Med., Jul;12(7):856-61 (2006)
Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker.
Neurology., Feb;68(9):666-9 (2007)
Stable isotope labeling tandem mass spectrometry (SILT) to quantify protein production and clearance rates.
J. Am. Soc. Mass Spectrom., Jun;18(6):997-1006 (2007)
Measuring target effect of proposed disease-modifying therapies in Alzheimer's disease.
Neurotherapeutics., Jul;5(3):381-90 (2008)
Method for the simultaneous quantitation of apolipoprotein E isoforms using tandem mass spectrometry.
Anal. Biochem., Dec;395(1):116-8 (2009)
Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle.
Science., Nov;326(5955):1005-7 (2009)
Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage.
J. Neurol. Neurosurg. Psychiatr., Feb;82(2):157-9 (2011)
Decreased clearance of CNS beta-amyloid in Alzheimer's disease.
Science., Dec;330(6012):1774 (2010)
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease.
Alzheimers Res Ther., 3(1):1 (2011)
A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system.
Ann. Neurol., Jul;66(1):48-54 (2009)
Î² adrenergic receptor modulation of neurotransmission to cardiac vagal neurons in the nucleus ambiguus.
Neuroscience., May;210:58-66 (2012)
Î±1-adrenergic receptors facilitate inhibitory neurotransmission to cardiac vagal neurons in the nucleus ambiguus.
Neuroscience., Oct;193:154-61 (2011)
Acute gamma-secretase inhibition of nonhuman primate CNS shifts amyloid precursor protein (APP) metabolism from amyloid-beta production to alternative APP fragments without amyloid-beta rebound
The Journal of Neuroscience
Decreased Clearance of CNS ÃŽÂ²-Amyloid in Alzheimer's Disease